Moneycontrol
HomeNewsBusinessQ2 report: As IT companies get back their hiring mojo, it's good news for both students and experienced

Q2 report: As IT companies get back their hiring mojo, it's good news for both students and experienced

Headcount in top four IT firms – TCS, Infosys, Wipro and HCL Tech – increased by 17,079 in September 2020 quarter. These were a mixture of freshers and laterals. The number declined by 9,000 in Q1.

October 20, 2020 / 18:04 IST
Story continues below Advertisement

India's IT industry, among the country's biggest employers, seems to have bounced back. Demand is getting back to pre-Covid-19 levels and top names in the sector have stepped up hiring.

The top four IT firms hired 17,000 in the second quarter after a net decline of 9,000 in the first. Also, a robust hiring plan in place for the December and March quarters, IT executives said.

Story continues below Advertisement

This is important, given that IT is one of the largest employers in the country, especially in engineering colleges. Continued contraction would have impacted job opportunities for fresh engineering graduates, where IT firms are major job providers.

Hiring in Q2 FY21

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show